Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMC119-06-05 in Older Adults With Pre-frailty & Frailty
NCT06501066Phase 2Active, not recruiting
- Sponsor
- Meribank Biotech Co., Ltd
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of UMC119-06-05 in frailty syndrome, sponsored by Meribank Biotech Co., Ltd. Started Jun 2024; status: active, not recruiting.
02
Drugs
UMC119-06-05
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT06501066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06501066.